Global Retirement Partners LLC Has $6.26 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Global Retirement Partners LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,994 shares of the medical equipment provider's stock after acquiring an additional 1,238 shares during the quarter. Global Retirement Partners LLC's holdings in Intuitive Surgical were worth $6,260,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the business. Massachusetts Financial Services Co. MA acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth about $558,807,000. International Assets Investment Management LLC increased its stake in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the period. FMR LLC raised its holdings in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after acquiring an additional 552,058 shares during the period. Finally, Strategic Financial Concepts LLC lifted its holdings in Intuitive Surgical by 50,740.8% during the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider's stock valued at $163,202,000 after purchasing an additional 312,056 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $14.78 on Friday, hitting $591.79. 1,673,828 shares of the company's stock were exchanged, compared to its average volume of 1,567,754. The firm has a 50-day moving average price of $565.45 and a 200-day moving average price of $524.52. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market cap of $210.78 billion, a P/E ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 408 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,348 shares of company stock worth $3,587,582. Corporate insiders own 0.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Bernstein Bank lifted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. UBS Group raised their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.